Patents Assigned to Merck Patents GmbH
  • Patent number: 10431704
    Abstract: This invention relates to a method for producing a photodetector based on the deposition of precursor system having a liquid phase. The photodetectors are characterized by a certain group of semiconductor materials which can be used as the absorber in solar-blind UV detectors. A facile route for the formation of thin layers of such absorber materials is disclosed.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: October 1, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Rebekah Hooker, Deepak Ranjan Deshmukh, Pawel Miskiewicz, Andreas Klyszcz, Klaus Bonrad, Thomas Albrecht
  • Publication number: 20190296242
    Abstract: The invention relates to polymers having at least one asymmetrical structural unit of the following formula (I): wherein A, B, Ar1, Ar2, Ar3 and Ar4, n, m, o and p can have the meaning as defined in claim 1, to methods for the production thereof and to the use thereof in electronic or optoelectronic devices, in particular in organic electroluminescent devices, so-called OLEDs (OLED=Organic Light Emitting Diodes). The present invention also relates to organic electroluminescent devices which contain said polymers.
    Type: Application
    Filed: November 27, 2017
    Publication date: September 26, 2019
    Applicant: Merck Patent GmbH
    Inventors: Beate Burkhart, Katja Maria Scheible, Nils Koenen, Holger Heil
  • Publication number: 20190292210
    Abstract: The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.
    Type: Application
    Filed: September 18, 2017
    Publication date: September 26, 2019
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich, Philipp Harbach, Anna Hayer, Esther Breuning
  • Publication number: 20190292458
    Abstract: Liquid-crystalline media containing one or more compounds of formula T and one or more compounds of formulae I, II and/or III, high-frequency components containing these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g., phased array antennas.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Applicant: Merck Patent GmbH
    Inventors: Dagmar KLASS, Carsten FRITZSCH
  • Publication number: 20190292457
    Abstract: The invention relates to a light modulation element as comprising, preferably consisting of a cholesteric liquid crystalline medium sandwiched between two opposing substrates, an electrode arrangement, which is capable to allow the application of an electric field, which is substantially perpendicular to the main plane of substrate or the layer of the cholesteric liquid crystalline medium, characterized in that one of the substrates is provided with a planar alignment layer adjacent to the cholesteric liquid crystalline medium and the other substrate is provided with a homeotropic alignment layer adjacent to the cholesteric liquid crystalline medium. The invention is further related to a method of production of said light modulation element and to the use of said light modulation element in various types of optical and electro-optical devices, such as electro-optical displays, liquid crystal displays (LCDs), non-linear optic (NLO) devices, and optical information storage devices.
    Type: Application
    Filed: May 15, 2017
    Publication date: September 26, 2019
    Applicant: Merck Patent GmbH
    Inventors: Bernd FIEBRANZ, Peter BEST, Meike KRUMWIEDE, Simon SIEMIANOWSKI
  • Publication number: 20190292460
    Abstract: Liquid-crystalline media comprising one or more compounds of formula D and one or more compounds selected from the group of compounds of formulae I, II and III, in which the occurring groups and parameters have the meanings defined in claim 1, and to high-frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas (e.g. phased array antennas).
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Dagmar KLASS, Carsten FRITZSCH
  • Publication number: 20190290590
    Abstract: The present invention relates to an improved powdered extrudate based on polyvinyl alcohol (PVA), which can be used for pharmaceutical products, and that, due to its improved properties, can be better filled into capsules and the capsules show stable immediate drug release kinetic without problem of particle aggregation. Furthermore, this invention refers to pharmaceutical capsule composition comprising extruded polyvinyl alcohol as carrier matrix and can improve the solubility of API within immediate release kinetic. Moreover, the capsule show also benefit than tablet regarding to the material cost, because just PVA and API, no additional excipients are needed for capsule.
    Type: Application
    Filed: November 1, 2017
    Publication date: September 26, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Mengyao ZHENG, Anja-Nadine KNUETTEL
  • Patent number: 10424739
    Abstract: The invention relates to arylamino compounds and to the use thereof in electronic devices, for example organic electroluminescent devices. The invention furthermore relates to electronic devices comprising one or more of the said compounds, for example as hole-transport materials in a corresponding functional layer of the device. The invention furthermore relates to a process for the preparation of the said compounds, and to a formulation comprising one or more of the said compounds.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: September 24, 2019
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Frank Voges, Arne Buesing, Christof Pflumm, Teresa Mujica-Fernaud, Christian Wirges
  • Patent number: 10421941
    Abstract: The invention relates to a process for improving the solubility of dry cell culture media. Some dry powder cell culture media show poor dissolving properties and result in turbid solutions when they are dissolved in aqueous solutions. Using a stepwise procedure in which the amino acids present in the non-dissolving part are identified and added to a new batch in other particle sizes significantly reduces that problem.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: September 24, 2019
    Assignee: Merck Patent GmbH
    Inventor: Joerg Von Hagen
  • Publication number: 20190284474
    Abstract: The present invention relates to a switching layer based on a liquid-crystalline mixture for use in an optical switching element. The invention also encompasses a switching element comprising the switching layer and a window element containing the switching element. The liquid crystalline mixture comprises a low-molecular liquid crystal component, a polymer component and a self-alignment additive for vertical alignment.
    Type: Application
    Filed: July 17, 2017
    Publication date: September 19, 2019
    Applicant: Merck Patent GmbH
    Inventors: Dong-Mee SONG, Jung-Min LEE, Yong-Hyun CHOI, Yong-Kuk YUN
  • Publication number: 20190288206
    Abstract: The present application relates to fluoranthenylamine compounds of a formula (I). These compounds are suitable for use in electronic devices. The present application further relates to processes for preparing the compounds mentioned, and to electronic devices comprising the compounds mentioned.
    Type: Application
    Filed: October 30, 2017
    Publication date: September 19, 2019
    Applicant: Merck Patent GmbH
    Inventors: Amir PARHAM, Dominik JOOSTEN, Aurélie LUDEMANN, Tobias GROSSMANN, Jonas KROEBER
  • Patent number: 10413562
    Abstract: The present invention provides novel pyrimidine and pyridine compounds according to Formula (I), Formula (II), Formula (III), Formula (IV) and Formula (V) their manufacture and use for the treatment of hyperproliferative diseases including, but not limited to, cancer, lupus, allergic disorders, Sjogren's disease and rheumatoid arthritis. In preferred embodiments, the present invention describes irreversible kinase inhibitors including, but not limited to, inhibitors of Bruton's tyrosine kinase.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: September 17, 2019
    Assignee: Merck Patent GmbH
    Inventors: Brian L. Hodous, Lesley Liu-Bujalski, Reinaldo Jones, Donald Bankston, Theresa L. Johnson, Igor Mochalkin, Ngan Nguyen, Hui Qiu, Andreas Goutopoulos, Nadia Brugger
  • Patent number: 10413614
    Abstract: The present invention relates to a conjugate containing at least one kidney-selective carrier molecule and at least one active compound which has a protective action for the kidney against nephrotoxic active compounds, to a process for the preparation of the conjugate, to the use thereof for the protection of the kidney against nephrotoxic active compounds, and to a medicament comprising the conjugate.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: September 17, 2019
    Assignee: Merck Patent GmbH
    Inventors: Armin Kuebelbeck, Gregor Larbig, Stefan Arnold, Walter Mier, Uwe Haberkorn
  • Patent number: 10418564
    Abstract: The invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: September 17, 2019
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Christof Pflumm, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Tobias Grossmann
  • Patent number: 10414743
    Abstract: The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: September 17, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Andreas Taugerbeck, Achim Goetz, Alexander Hahn, Martin Engel
  • Patent number: 10416518
    Abstract: The invention provides a light modulation element comprising a flexoelectric polarisable liquid-crystalline medium, characterized in that the switching from a boundary state A to a boundary state B comprises a combination of a distinct flexoelectric switching regime and a distinct dielectric switching regime upon application of an electric field. Furthermore, the present invention relates to the use of such a light modulation element in an electro-optical device, i.e. an LCD display device, and electrooptical devices comprising the light modulation element according to the present invention. Moreover, the invention relates to a method of production of the light modulation element according to the present invention.
    Type: Grant
    Filed: November 28, 2014
    Date of Patent: September 17, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Rachel Tuffin, Rebecca Proctor, Simon Siemianowski, Karl Skjonnemand, Owain Llyr Parri, Geoffrey Luckhurst
  • Publication number: 20190280220
    Abstract: The present invention relates to metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.
    Type: Application
    Filed: October 23, 2017
    Publication date: September 12, 2019
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Christian Ehrenreich
  • Publication number: 20190274961
    Abstract: The present invention relates to an improved powdered extrudate based on polyvinyl alcohol (PVA), which can be used for the production of pharmaceutical products, and due to its improved properties, can be better directly compressed into tablets. Furthermore, this invention refers to pharmaceutical tablets composition comprising extruded polyvinyl alcohol as carrier matrix, which is suitable to improve the solubility of API within a controlled release (instant or sustained) kinetic.
    Type: Application
    Filed: November 6, 2017
    Publication date: September 12, 2019
    Applicant: Merck Patent GmbH
    Inventors: Mengyao ZHENG, Nicole DI GALLO, Anja-Nadine KNUETTEL
  • Publication number: 20190276397
    Abstract: The present invention relates to novel compounds containing fluorinated end groups, to the use thereof as surface-active substances, and to compositions comprising these compounds.
    Type: Application
    Filed: November 1, 2017
    Publication date: September 12, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Reiner FRIEDRICH, Fabian KOCH
  • Publication number: 20190280217
    Abstract: The invention relates to compounds which are suitable for use in electronic devices, and electronic devices, in particular organic electroluminescent devices, containing said compounds.
    Type: Application
    Filed: April 22, 2019
    Publication date: September 12, 2019
    Applicant: Merck Patent GmbH
    Inventors: Anja JATSCH, Tobias GROSSMANN, Amir HOSSAIN, Thomas EBERLE, Christof PFLUMM, Jonas Valentin KROEBER, Philipp STOESSEL, Elvira MONTENEGRO, Rouven LINGE